Navigation Links
Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor
Date:7/26/2010

LIVERMORE, Calif., July 26 /PRNewswire/ -- Halt Medical, Inc. announced today that Robert J. Rubin, M.D. has been appointed to its Scientific Advisory Board.  Dr. Rubin will also be a consultant to the company, helping to develop and implement comprehensive reimbursement strategies.  Dr. Rubin's distinguished career has included significant contributions in the fields of medicine, government, and business. Currently, he is Clinical Professor of Medicine at Georgetown University's School of Medicine and serves as a consultant to several international healthcare companies. Among his positions in government, Dr. Rubin served as Assistant Secretary, U.S. Department of Health and Human Services (DHHS), concurrent with his appointment as Assistant Surgeon General from 1981 to 1984.  Among his positions in business, Dr. Rubin served as president of the leading healthcare consulting firm, The Lewin Group, Inc., and its predecessor organizations, from 1987 to 2001.

"Dr. Rubin brings to Halt Medical significant medical and business expertise", commented Jeff Cohen, Halt's Chief Executive Officer.  "While Dr. Rubin was at the DHHS, he was responsible for passage of Medicare's Prospective Payment System.  His guidance will add significant value to Halt, particularly in the areas of public and private sector reimbursement strategies for the Halt Fibroid Procedure".  

About Halt Medical, Inc.

Halt Medical, Inc. is a late-stage medical device design and manufacturing company developing products to ablate tissue with its next generation Radiofrequency Volumetric Thermal Ablation (RFVTA) system.  The Halt system has been cleared by the FDA for general use and is currently being studied in the US for relief of symptoms caused by uterine fibroids.  Halt is preparing to commercialize the Halt Fibroid System in Europe where it has recently obtained the CE mark for general and fibroid indications.  The worldwide business opportunity for the Halt Fibroid System is estimated to be over $2 billion annually.  

Information about the Halt Fibroid Study and a list of clinical sites in the U.S. may be found at

www.clinicaltrials.gov, study number NCT00874029.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
4. Veridiam Names Robert Mazzacavallo New CFO
5. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
6. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
7. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
8. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
9. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
10. PolyTouch Medical Ltd. Announces the Appointment of Robert D. Fanelli, MD, FACS, FASGE as Medical Advisor
11. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/9/2017)... ... ... Monday, September 18 th .The Brain Tumor Foundation (BTF) begins a week-long ... BTF,s Mobile MRI Unit – a 70 Ft. ... brings its nationwide initiative, the Road to Early Detection Sponsor-A-City Campaign to ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
Breaking Medicine News(10 mins):